SCHEMBL7977394

SCHEMBL7977394

C/C=C\N=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070691 1.00
SCHEMBL19156417 0.78
SCHEMBL14496823 0.78
SCHEMBL22944732 0.76
SCHEMBL13920325 0.73
SCHEMBL15061676 0.73
SCHEMBL16193068 0.73
SCHEMBL18768264 0.73
SCHEMBL13551029 0.73
SCHEMBL16204327 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357181-A1 METHODS AND COMPOUNDS USEFUL IN THE SYTHESIS OF AN AAK1 INHIBITOR LEXICON PHARMACEUTICALS, INC. 2023-11-09 US disclosed
US-20230339982-A1 CHEMICAL COMPOUND, USE OF AT LEAST ONE SUCH CHEMICAL COMPOUND IN AN OPTOELECTRONIC COMPONENT, AND OPTOELECTRONIC COMPONENT CONTAINING AT LEAST ONE SUCH CHEMICAL COMPOUND TECHNISCHE UNIVERSITAET DRESDEN (DE) 2023-10-26 US disclosed
WO-2021087093-A1 SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-05-06 WO disclosed
WO-2021055630-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL- BIOTECH INVESTMENTS, INC. (US) 2021-03-25 WO disclosed
US-20210061810-A1 PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE DERIVATIVES AS PROTEIN KINASE INHIBITORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2021-03-04 US disclosed
WO-2017191599-A1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2017-11-09 WO disclosed
EP-2688403-B1 OPIOID RECEPTOR LIGANDS AND METHODS OF USING AND MAKING SAME TREVENA INC (US) 2017-05-31 EP disclosed
EP-3168847-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFICATION PRODUCT THEREOF Fujifilm Corporation (JP) 2017-05-17 EP disclosed
EP-2078003-B1 ANILINOPIPERAZINE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME (US) 2017-03-08 EP disclosed
EP-1905829-B1 Templated molecules and methods for using such molecules NUEVOLUTION AS (DK) 2016-02-17 EP disclosed
EP-1479397-B1 2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE ASTELLAS PHARMA INC (JP) 2011-06-08 EP disclosed
WO-2010005534-A2 PROTEASOME INHIBITORS FOR SELECTIVELY INDUCING APOPTOSIS IN CANCER CELLS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2010-01-14 WO disclosed
US-20030153754-A1 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands NEUROGEN CORPORATION, A CORPORATION OF THE STATE OF DELAWARE 2003-08-14 US disclosed
US-4487947-A POLYAMIDES, CURING AGENTS, EPOXY RESINS CIBA-GEIGY CORPORATION (US) 1984-12-11 US disclosed
US-4484004-A CURING AGENT FOR EPOXY RESIN AND POLYAMIDES CIBA-GEIGY CORPORATION (US) 1984-11-20 US disclosed
US-4460790-A PRODUCING POLYAMIDES, CURING AGENTS FOR EPOXIDE RESINS CIBA-GEIGY CORPORATION (US) 1984-07-17 US disclosed
US-4355177-A Substituted 11-amino-undeca-4,8-dienal and 11-amino-undecanal derivatives and processes for their preparation CIBA-GEIGY CORPORATION (US) 1982-10-19 US disclosed
US-4332969-A Substituted 11-aminoundecanols CIBA-GEIGY CORPORATION (US) 1982-06-01 US disclosed
US-4277621-A OXIMES AND HYDRAZONES; INTERMEDIATES FOR DIAMINES FOR POLYAMIDES OR CURING EPOXY RESINS CIBA-GEIGY CORPORATION (US) 1981-07-07 US disclosed
US-4213901-A PESTICIDES CIBA-GEIGY CORPORATION (US) 1980-07-22 US disclosed